Chen, R., Hou, J., Newman, E., Kim, Y., Donohue, C., Liu, X., . . . Kane, S. E. (2015). CD30 downregulation, MMAE resistance, and MDR1 upregulation are all associated with resistance to brentuximab vedotin. Mol Cancer Ther.

Chen, Robert, Jessie Hou, Edward Newman, Young Kim, Cecile Donohue, Xueli Liu, Sandra H. Thomas, Stephen J. Forman, und Susan E. Kane. "CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated With Resistance to Brentuximab Vedotin." Mol Cancer Ther 2015.

Chen, Robert, et al. "CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated With Resistance to Brentuximab Vedotin." Mol Cancer Ther 2015.